KUALA LUMPUR, Sept 8 (Bernama) -- Bursa Malaysia closed almost flat on Tuesday as buying interest rotated away from index heavyweights towards smaller-cap construction stocks, with sentiment affected by geopolitical uncertainty, said an analyst. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) eased 0.39 of a point to 1,714.40 from Monday’s close of 1,714.79. The benchmark index opened 1.65 points lower at 1,713.14 and moved between 1,710.44 and 1,714.50 throughout the trading session. The broader market was almost evenly balanced, with decliners leading gainers 548 to 546, while 598 counters were unchanged, 1,107 were untraded and 25 were suspended. Turnover expanded to 4.13 billion units valued at RM3.14 billion from 3.60 billion units valued at RM2.45 billion on Monday.
JD Health, China’s leading online healthcare platform and pharmacy operator, continues to deliver robust fundamentals with three-year net profit CAGR projected at 15% and stable net margins of 6%–7% . Backed by rising demand for digital healthcare, an aging population, and a growing focus on wellness and prevention, JD Health is positioning itself as a long-term structural growth story in the consumer healthcare space. Technical Strength The stock has rebounded above its 20-day EMA on stronger volume. The MACD line is trading above its signal, confirming short-term momentum. With support at HKD 41.80, a move toward HKD 44.60 is likely. 📊 Financial Highlights FY Revenue (HKD m) Net Profit (HKD m) 2025F 72,874 4,938 2026F 82,269 5,506 2027F 92,522 6,211 Why We Like JD Health Leader in online pharmacy and integrated healthcare services. Strong scalability with an expanding user base and product portfolio. Resilient e-commerce distribution model in a fas...